Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,001 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE Trial.
Ottani F, Latini R, Staszewsky L, La Vecchia L, Locuratolo N, Sicuro M, Masson S, Barlera S, Milani V, Lombardi M, Costalunga A, Mollichelli N, Santarelli A, De Cesare N, Sganzerla P, Boi A, Maggioni AP, Limbruno U; CYCLE Investigators. Ottani F, et al. Among authors: lombardi m. J Am Coll Cardiol. 2016 Feb 2;67(4):365-374. doi: 10.1016/j.jacc.2015.10.081. J Am Coll Cardiol. 2016. PMID: 26821623 Free article. Clinical Trial.
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).
Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B; REBOOT-CNIC investigators. Rossello X, et al. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34351426 Clinical Trial.
Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry).
Pepe M, Sardella G, Stefanini GG, Corcione N, Nestola PL, Morello A, Briguori C, Tamburino C, Fabbiocchi F, Rotolo FL, Tomai F, Paggi A, Lombardi M, Gioffrè G, Sclafani R, Rolandi A, Sciahbasi A, Scardaci F, Signore N, Mancone M, Giordano A. Pepe M, et al. Among authors: lombardi m. Am J Cardiol. 2019 Nov 15;124(10):1518-1527. doi: 10.1016/j.amjcard.2019.08.015. Epub 2019 Aug 23. Am J Cardiol. 2019. PMID: 31547997
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study.
Sardella G, Stefanini GG, Briguori C, Tamburino C, Fabbiocchi F, Rotolo F, Tomai F, Paggi A, Lombardi M, Gioffrè G, Sclafani R, Rolandi A, Sciahbasi A, Scardaci F, Signore N, Calcagno S, Mancone M, Chiarito M, Giordano A. Sardella G, et al. Among authors: lombardi m. EuroIntervention. 2018 Sep 20;14(7):772-779. doi: 10.4244/EIJ-D-18-00148. EuroIntervention. 2018. PMID: 29784631 Free article.
Exercise dose in clinical practice: Right is better than more.
Leggio M, Bendini MG, D'Emidio S, Caldarone E, Lombardi M, Severi P, Stavri DC, Armeni M, Bravi V, Mazza A. Leggio M, et al. Among authors: lombardi m. Cardiol J. 2018;25(2):287-288. doi: 10.5603/CJ.2018.0040. Cardiol J. 2018. PMID: 29717780 Free article. No abstract available.
Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients.
Wiemer M, Danzi GB, West N, Voudris V, Koning R, Hoffmann S, Lombardi M, Mauri J, Babic R, Witherow F. Wiemer M, et al. Among authors: lombardi m. Med Devices (Auckl). 2015 Feb 18;8:153-60. doi: 10.2147/MDER.S67399. eCollection 2015. Med Devices (Auckl). 2015. PMID: 25737640 Free PMC article.
1,001 results